Public Employees Retirement Association of Colorado’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-32,231
Closed -$110K 1889
2018
Q3
$110K Hold
32,231
﹤0.01% 1793
2018
Q2
$121K Hold
32,231
﹤0.01% 1716
2018
Q1
$132K Hold
32,231
﹤0.01% 1687
2017
Q4
$150K Hold
32,231
﹤0.01% 1686
2017
Q3
$229K Hold
32,231
﹤0.01% 1510
2017
Q2
$233K Hold
32,231
﹤0.01% 1514
2017
Q1
$199K Hold
32,231
﹤0.01% 1555
2016
Q4
$189K Hold
32,231
﹤0.01% 1596
2016
Q3
$171K Hold
32,231
﹤0.01% 1608
2016
Q2
$213K Hold
32,231
﹤0.01% 1544
2016
Q1
$151K Buy
32,231
+17,167
+114% +$68.5K ﹤0.01% 1667
2015
Q4
$76K Hold
15,064
﹤0.01% 1813
2015
Q3
$53K Hold
15,064
﹤0.01% 1867
2015
Q2
$150K Buy
+15,064
New +$162K ﹤0.01% 1749

Public Employees Retirement Association of Colorado's KERX Position: Q4 2018 in Review

Public Employees Retirement Association of Colorado sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 32,231 shares — an estimated $110K sold.

Public Employees Retirement Association of Colorado first reported a position in KERX in Q2 2015 and held it in 14 quarters. The position peaked at $233K in Q2 2017. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

  • Public Employees Retirement Association of Colorado reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
  • Public Employees Retirement Association of Colorado sold 32,231 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $110K.
  • Public Employees Retirement Association of Colorado first reported a position in Keryx Biopharmaceuticals Inc in Q2 2015 and held it in 14 quarters.
  • Public Employees Retirement Association of Colorado's Keryx Biopharmaceuticals Inc position peaked at $233K in Q2 2017.
  • 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Public Employees Retirement Association of Colorado's 13F filing for Q4 2018, filed 8 Feb 2019.